Soon-Shiong’s NantCell raises another $57M for immuno-oncology work

Damian Garde

Billionaire entrepreneur Patrick Soon-Shiong's raised $ 57.3 million in equity to fund its on treatments that use the immune system to fight cancer, becoming one of the most well-funded companies in its founder's constellation of biotech endeavors.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS